These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 18178907)

  • 21. Testosterone and mortality.
    Muraleedharan V; Jones TH
    Clin Endocrinol (Oxf); 2014 Oct; 81(4):477-87. PubMed ID: 25041142
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association of testosterone levels with endothelial function in men: results from a population-based study.
    Empen K; Lorbeer R; Dörr M; Haring R; Nauck M; Gläser S; Krebs A; Reffelmann T; Ewert R; Völzke H; Wallaschofski H; Felix SB
    Arterioscler Thromb Vasc Biol; 2012 Feb; 32(2):481-6. PubMed ID: 22095984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Sex hormones, HDL cholesterol and other lipoproteins in older males].
    Barud W; Palusiński R; Piotrowska-Swirszcz A; Ostrowski S; Makaruk B
    Pol Merkur Lekarski; 2005 Mar; 18(105):295-7. PubMed ID: 15997636
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels.
    Dougherty RH; Rohrer JL; Hayden D; Rubin SD; Leder BZ
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):228-35. PubMed ID: 15670201
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular events.
    Corona G; Rastrelli G; Maseroli E; Fralassi N; Sforza A; Forti G; Mannucci E; Maggi M
    Andrology; 2014 Sep; 2(5):741-7. PubMed ID: 25044637
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prospective association of low total testosterone concentrations with an adverse lipid profile and increased incident dyslipidemia.
    Haring R; Baumeister SE; Völzke H; Dörr M; Felix SB; Kroemer HK; Nauck M; Wallaschofski H
    Eur J Cardiovasc Prev Rehabil; 2011 Feb; 18(1):86-96. PubMed ID: 20562628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. cGMP level in idiopathic Parkinson's disease patients with and without cardiovascular disease - A pilot study.
    Brodacki B; Chalimoniuk M; Wesołowska J; Staszewski J; Chrapusta SJ; Stępień A; Langfort J
    Parkinsonism Relat Disord; 2011 Nov; 17(9):689-92. PubMed ID: 21802341
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Testosterone and cardiovascular risk.
    Tirabassi G; Gioia A; Giovannini L; Boscaro M; Corona G; Carpi A; Maggi M; Balercia G
    Intern Emerg Med; 2013 Apr; 8 Suppl 1():S65-9. PubMed ID: 23475207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testosterone and cardiovascular risk in men.
    Kelly DM; Jones TH
    Front Horm Res; 2014; 43():1-20. PubMed ID: 24943294
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women.
    Maturana MA; Breda V; Lhullier F; Spritzer PM
    Metabolism; 2008 Jul; 57(7):961-5. PubMed ID: 18555838
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Testosterone and modifiable risk factors associated with diabetes in men.
    Atlantis E; Lange K; Martin S; Haren MT; Taylor A; O'Loughlin PD; Marshall V; Wittert GA
    Maturitas; 2011 Mar; 68(3):279-85. PubMed ID: 21247710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Plasma total testosterone and incident cardiovascular events in hypertensive patients.
    Vlachopoulos C; Ioakeimidis N; Terentes-Printzios D; Aznaouridis K; Rokkas K; Aggelis A; Synodinos A; Lazaros G; Stefanadis C
    Am J Hypertens; 2013 Mar; 26(3):373-81. PubMed ID: 23382488
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease.
    Joffe HV; Ridker PM; Manson JE; Cook NR; Buring JE; Rexrode KM
    Ann Epidemiol; 2006 Feb; 16(2):105-12. PubMed ID: 16216530
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The androgen receptor CAG repeat polymorphism as a risk factor of low serum testosterone and its cardiometabolic effects in men.
    Haring R; Ernst F; Schurmann C; Homuth G; Völker U; Völzke H; Nauck M; Wallaschofski H
    Int J Androl; 2012 Aug; 35(4):511-20. PubMed ID: 21950564
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular disease and androgens: a review.
    Kaushik M; Sontineni SP; Hunter C
    Int J Cardiol; 2010 Jun; 142(1):8-14. PubMed ID: 19923015
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiovascular effects of androgen depletion and replacement therapy.
    Pinthus JH; Trachtenberg J; Klotz L
    Urology; 2006 Jun; 67(6):1126-32. PubMed ID: 16765164
    [No Abstract]   [Full Text] [Related]  

  • 37. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
    Miner MM; Khera M; Bhattacharya RK; Blick G; Kushner H
    Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Testosterone deficiency in elderly men].
    Rabijewski M; Zgliczyński W
    Pol Merkur Lekarski; 2009 Dec; 27(162):517-23. PubMed ID: 20120721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gender differences in the relation of insulin-like growth factor binding protein-1 to cardiovascular risk factors: a population-based study.
    Undén AL; Elofsson S; Brismar K
    Clin Endocrinol (Oxf); 2005 Jul; 63(1):94-102. PubMed ID: 15963068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MANopause (andropause).
    Varner JM
    Ala Nurse; 2013; 40(1):7-8; quiz 9. PubMed ID: 23550372
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.